Skip to content

Internet-based CBT After Stroke Pilot

Internet-based Cognitive Behavioral Therapy to Reduce Depressive Symptoms After Stroke Pilot/Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03615079
Acronym
iSAD
Enrollment
28
Registered
2018-08-03
Start date
2018-06-11
Completion date
2021-07-30
Last updated
2021-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Stroke

Brief summary

Mood disorders occur in 25-30% of stroke patients and are associated with lower quality of life, higher mortality, increased healthcare utilization, and higher costs. Cognitive behavioral therapy (CBT) interventions have been shown to both treat and prevent post-stroke mood disorders, thus having the ability to improve quality of life and reduce costs. This study aims to test the feasibility of internet-based CBT combined with a telephone/email based coaching service after stroke.

Interventions

BEHAVIORALCognitive behavioral therapy

An 8-week, internet-based cognitive behavioral therapy (CBT) program for depression

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years of age * Acute ischemic stroke within the past 3 months * Regular access to the internet, sufficient to allow a minimum of interactions with the internet daily, either through a personal smartphone or web-based internet browser. * Subject is willing and able to participate in internet-based cognitive behavioral therapy * Can participate in the program in English * Willingness and ability to sign informed consent by the patient * Symptoms of mild to moderately depressed mood, defined as a score of 5-19 on the Patient Health Questionnaire-9 at the time of study enrollment.

Exclusion criteria

* Severely depressed patients, defined by a score of 20+ on the Patient Health Questionnare-9 are excluded * Patients with an active bipolar disorder diagnosis are excluded * Patients with personality disorder diagnoses are excluded * Patients with active suicidality or past suicide attempts are excluded * History of schizophrenia or schizoaffective disorder * Active participation in face-to-face psychotherapy prior to stroke * Patients with a history of dementia are excluded * Patients with aphasia, defined as a score of 1 or greater on NIH Stroke Scale Item 9 are excluded. * Patients without regular internet access through a computer, tablet or smartphone are excluded. * Subjects requiring long-term inpatient nursing care are excluded. For patients enrolled as inpatients, individuals being discharged to both home and acute rehab are eligible. Individuals being discharged to a skilled nursing facility or hospice are excluded. * Expected life expectancy less than 6 months or other inability to comply with study follow-up. * Pregnant women and prisoners are excluded

Design outcomes

Primary

MeasureTime frameDescription
Change in Depressive Symptoms Over TimeBaseline and 90 daysSubject's depressive symptoms will be quantified using the Patient Health Questionnaire 9. This assessment includes 9 close-ended questions with a scoring system ranging from 0 to 27. Scores greater than 10 are considered positive for depressive symptoms. We will compare the average PHQ-9 score at study enrollment to the PHQ-9 at 90 days to determine the reduction in depressive symptoms over time.

Secondary

MeasureTime frameDescription
Quality of Life Assessed by the EuroQOL-5D90 daysEuroQOL-5D questionnaire that measures health related quality of life. The scale ranges from 1 to 100, with higher scores indicating better outcomes.

Countries

United States

Participant flow

Pre-assignment details

The proportion of subjects who engaged with the CBT application was not what was expected and as such enrollment was expanded with the goal of getting 20 subjects to use the application.

Participants by arm

ArmCount
Cognitive Behavioral Therapy (CBT) Program
Cognitive behavioral therapy: An 8-week, internet-based cognitive behavioral therapy (CBT) program for depression
11
Total11

Baseline characteristics

CharacteristicCognitive Behavioral Therapy (CBT) Program
Age, Continuous55.3 years
STANDARD_DEVIATION 14.7
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
6 Participants
Region of Enrollment
United States
11 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 28
other
Total, other adverse events
0 / 28
serious
Total, serious adverse events
0 / 28

Outcome results

Primary

Change in Depressive Symptoms Over Time

Subject's depressive symptoms will be quantified using the Patient Health Questionnaire 9. This assessment includes 9 close-ended questions with a scoring system ranging from 0 to 27. Scores greater than 10 are considered positive for depressive symptoms. We will compare the average PHQ-9 score at study enrollment to the PHQ-9 at 90 days to determine the reduction in depressive symptoms over time.

Time frame: Baseline and 90 days

Population: 1 subject missing day 90 PHQ-9

ArmMeasureValue (MEDIAN)
Cognitive Behavioral Therapy (CBT) ProgramChange in Depressive Symptoms Over Time6 scores on scale
Secondary

Quality of Life Assessed by the EuroQOL-5D

EuroQOL-5D questionnaire that measures health related quality of life. The scale ranges from 1 to 100, with higher scores indicating better outcomes.

Time frame: 90 days

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy (CBT) ProgramQuality of Life Assessed by the EuroQOL-5D73 scores on a scaleStandard Deviation 16

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026